CHANGE IN RATINGS

American Campus ( ACC) coverage resumed at Bank of America/Merrill Lynch with a Buy rating as college housing is inelastic to economic factors. 2009 and 2010 EPS estimates set at $1.56 and $1.68, respectively. $26 target price.

Allergan ( AGN) upgraded at Citigroup from Hold to Buy. $57 price target. Expect higher Botox sales, and Latisse guidanc appears conservative.

Akamai ( AKAM) upgraded at Kaufman from Sell to Hold. $21.75 price target. Recent checks suggest that value-added services performed better in the second quarter.

Bank of America ( BAC) downgraded at Fox-Pitt from Outperform to In-Line. $13 price target. Company is struggling to generative positive core earnings.

BJ Services ( BJS) downgraded at Wells Fargo to Underperform. See pressure pumping margins falling even further. Stock could have 31%-38% downside potential.

Peabody Energy ( BTU) upgraded at Friedman, Billings Ramsey to Outperform. $44 price target. Long-term steel and steam demand trends from India and China should drive growth.

Cameron International ( CAM) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $40 from $24. 2009 EPS estimates raised to $1.85 from $1.80.

Caterpillar ( CAT) upgraded at Merrill/BofA to Buy from Neutral as construction market shows a bottom. Price target raised to $45 from $36. 2009 and 2010 EPS estimates set at $0.91 and $1.27, respectively.

Cisco ( CSCO) upgraded at Credit Suisse to Outperform from Neutral. The raise in numbers was prompted by its expected earnings momentum and public data points that suggest business trends are improving. Increased price target to $25 from $22.

Danaher ( DHR) upgraded at Morgan Stanley from Equal-weight to Overweight. $73 price target. Expect more deal announcements and the stock has lost its premium valuation.

FMC Technologies ( FTI) upgraded at JP Morgan to Neutral from Underweight. Price target raised to $48 from $30. 2009 EPS estimates raised to $0.42 from $0.33.

WW Grainger ( GWW) upgraded at Morgan Stanley from Underweight to Equal-weight. $85 price target. Company is executing well and gaining market share through a severe sales recession.

Human Genome ( HGSI) upgraded at Citigroup from Hold to Buy. $17 price target. Now expect 2012 earnings of 88 cents a share.

Human Genome ( HGSI) upgraded at Lazard from Sell to Hold. Company will still need positive data from a second Lupus trial to receive FDA approval.

Harley Davidson ( HOG) upgraded at Goldman to Neutral from Sell. As refinancing risks have diminished and that guidance has been dramatically lowered, the co.'s expectations have been set very low to where a long term scenario could pay out for investors. Raised target price to $20 from $11.

Intuitive Surgical ( ISRG) upgraded at William Blair to Outperform. Estimates also raised, as checks show strong demand for new systems and procedure volumes.

Palm ( PALM) rated new Sell at Jesup & Lamont. $12.50 price target. Stock is already pricing in higher Pre sales, but a lot of returns have been based on poor keyboard performance.

Terex ( TEX) upgraded at Merrill/BofA from Underperform to Neutral as capital injection should provide cash cushion through downturn. Price target lifted to $15 from $12. 2009 and 2010 EPS estimates set at -$1.55 and -$0.96, respectively.

Tyson Foods ( TSN) downgraded at Deutsche Bank. Rating lowered to Hold from Buy. Price target lowered to $14 from $15. Maintains 2009 EPS estimates of $0.16.

Texas Instruments ( TXN) upgraded at Jefferies from Underperform to Hold. $23 price target. Checks indicate that September quarter results will come in well ahead of expectations.

STOCK COMMENTS / EPS CHANGES

Apple ( AAPL) estimates raised at Goldman for FY 2009 to $5.50 from $5.43 and for FY 2010 to $6.25 from $6.18. The co.'s product segments remain well positioned in a seasonally strong back half of the year and estimates are expected to be in-line or slightly better for the June-quarter. Maintained Neutral rating and target price of $160.

Advanced Micro ( AMD) estimates, target raised at FBR to $5.25. Estimates also boosted, given solid PC channel checks. Market Perform rating.

AptarGroup ( ATR) price target, estimates raised at Merrill/BofA to $37 from $36. 2009 and 2010 EPS estimates lifted to $1.75 from $1.65 and to $1.90 from $1.85. Maintain Neutral rating.

Bank of America ( BAC) estimate slashed. Barclays lowered BAC's 2009 EPS estimate to $0.50 from $0.70. Reiterate $17 price target and 2010 EPS estimate of $1.10. Equal Weight rating.

BB&T ( BBT) estimates reduced through 2010 at Friedman, Billings Ramsey. Credit performance is falling in Atlanta and the Carolinas. Market Perform rating and $20 price target.

Beckman Coulter ( BEC) price target raised at Merrill/BofA to $68 from $63. Maintain 2009 and 2010 EPS estimates of $3.80 and $4.60, respectively. Reiterate Buy rating.

Bemis ( BMS) target, estimates raised at Merrill/BofA. Price target to $27 from $26. 2009 and 2010 EPS estimates inflated to $1.72 from $1.63 and to $1.80 from $1.75, respectively. Maintain Underperform rating.

Brocade Communications ( BRCD) target raised at Goldman to $9 from $8. Due to the high growth in handsets and PCs, the firm believes that the co. will report current quarter results above guidance and deliver Q3 earnings well above expectations. Maintained Buy rating.

Broadcom ( BRCM) estimates, target increased. Estimates raised through 2010 at Friedman, Billings Ramsey. Channel checks suggest that the company's quarter ran at or above plan. Outperform rating and new $31 price target.

Citigroup ( C) 2009 estimate increased at Barclays from -$0.55 to $0.15 as Citicorp branch stays profitable. Maintain $3 price target and 2010 EPS estimate of $0.40. Overweigh rating.

First Horizon National ( FHN) price target increased at Merrill/BofA to $13 from $12 as credit improves. 2009 and 2010 EPS estimates set at -$1.40 and $0.25, respectively. Reiterate Neutral rating.

General Electric ( GE) target lowered at Goldman to $13 from $16 based on valuation and the risk that the US financial regulatory reform could prompt a GECS spin-off after a five year transition resulting in high taxes and costs. Maintained Neutral rating.

General Electric ( GE) 2009 estimates boosted at Morgan Stanley to reflect solid margin and cash flow performance, Morgan Stanley said. Overweight rating and $17 price target.

General Electric ( GE) 2010 estimate cut at Barclays to $0.85 from $1.00. Maintain $15 price target and 2009 EPS estimate of $1.00. Overweight rating.

JP Morgan ( JPM) estimates, target cut at Morgan Stanley. Shares of JPM now seen reaching $58. Estimates also lowered, Taking a more conservative credit outlook and see lower card/consumer fees. Overweight rating.

Mattel ( MAT) price target raised, estimates changed at Barclays. Barclays inflated MAT's price target to $20 from $14 on top line growth and cost cutting. 2009 EPS estimate cut to $1.15 from $1.17 and 2010 EPS estimate increased to $1.45 from $1.42. Maintain Equal Weight rating.

Moody's ( MCO) price target, estimates raised at Barclays. Barclays increased MCO's price target to $34 from $33 on attractive valuation. 2009 and 2010 EPS estimates lifted to a street-high of $1.65 from $1.60 and to $1.95 from $1.90, respectively. Maintain Overweight rating.

McGraw-Hill ( MHP) price target, estimates lifted at Barclays. MHP price target to $38 from $37 as the stock is oversold in recent months. 2009 and 2010 EPS estimates increased to $2.10 from $2.05 and to $2.55 from $2.50, respectively. Maintain Overweight rating.

Mead Johnson Nutrition ( MJN) price target boosted at Merrill/BofA to $35 from $32 on Asian demand. Reiterate 2009 and 2010 EPS estimates of $2.01 and $2.22, respectively. Neutral rating.

National Oilwell Varco ( NOV) target raised at JP Morgan. Price target raised to $35 from $30. Maintains Underweight rating and 2009 EPS estimates of $3.45.

Nvidia ( NVDA) numbers boosted at Friedman, Billings Ramsey. Shares of NVDA now seen reaching $14. Estimates also raised, to reflect positive retail channel checks and a related PC vendor survey. Market Perform rating.

NYSE Euronext ( NYX) target lowered at Goldman to $28 from $32 as market share continues to be lost over the quarter and that business trends for the co. has been more stabilization and loss than any sustained increase. Maintained Neutral rating.

Oceaneering International ( OII) numbers raised at JP Morgan. Price target raised to $65 from $42. EPS estimates raised to $3.35 from $3.30. Maintains Overweight rating.

People's United ( PBCT) target, estimates lowered at Barclays to $17 from $19 on missed earnings. 2009 and 2010 EPS estimates decreased to $0.30 from $0.33 and to $0.33 from $0.41, respectively. Maintain Equal Weight rating.

PPG ( PPG) numbers raised at UBS. Ttarget raised to $42 from $36. 2009 EPS estimates raised to $2.50 from $2.15. Maintains Sell rating.

Sunpower ( SPWRA) estimates, target cut at Jefferies to $34. Estimates also lowered, to reflect weak financing in the solar end markets. Buy rating.

AT&T ( T) 2009 estimates trimmed at Morgan Stanley to reflect higher iPhone sales. Will lead to larger near-term subsidies. Overweight rating and $32 price target.

Webster Financial ( WBS) target raised, estimates changed at Barclays. Price target to $11 from $7 on stronger capital and clearer path to profitability. 2009 EPS estimate slashed to -$1.79 from -$1.33 and 2010 EPS estimate raised to $0.66 from $0.61. Maintain Equal Weight rating.

This article was written by a staff member of TheStreet.com.

More from Stocks

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Danica Patrick's Final Race at 2018 Indianapolis 500: What She Thinks About Cars

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

Why The FANG Stocks' Dominance May Not Be So Bad For The Market

At End of May, Investors Signalling They May Stay Away

At End of May, Investors Signalling They May Stay Away

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever